Benjamin J Umlauf is an accomplished inventor based in Menlo Park, CA. He has made significant contributions to the field of antigen delivery systems. His innovative work focuses on enhancing the effectiveness of immunogenic therapies.

Latest Patents

Umlauf holds a patent for an antigen delivery system. This minimal antigen delivery system consists essentially of PEGylated stealth liposomes loaded with an immunogenic human leukocyte antigen (HLA) class restricted peptide. The system is surface modified with a cell targeting peptide, which mediates binding and internalization of the liposomes into a target cell. This patent represents a significant advancement in targeted drug delivery.

Career Highlights

Umlauf is currently associated with SRI International, where he continues to develop innovative solutions in biomedical research. His work has the potential to impact various therapeutic areas, particularly in immunology.

Collaborations

Umlauf collaborates with various professionals in his field, including his coworker, Kathlynn C Brown. Their combined expertise contributes to the advancement of research and development in antigen delivery systems.

Conclusion

Benjamin J Umlauf's contributions to the field of antigen delivery systems exemplify the importance of innovation in biomedical research. His work continues to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.